• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物诱导CD-1野生型小鼠肥胖和肝脂肪变性。

Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice.

作者信息

Sayej Wael N, Knight Iii Paul R, Guo Weidun Alan, Mullan Barbara, Ohtake Patricia J, Davidson Bruce A, Khan Abdur, Baker Robert D, Baker Susan S

机构信息

Digestive Diseases, Hepatology and Nutrition Center, Connecticut Children's Medical Center, Hartford, CT 06106, USA; University of Connecticut School of Medicine, Farmington, CT 06032, USA.

Department of Anesthesiology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA; Veterans Administration Western New York Healthcare System, State University of New York at Buffalo, Buffalo, NY 14215, USA; Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA.

出版信息

Biomed Res Int. 2016;2016:7867852. doi: 10.1155/2016/7867852. Epub 2016 Jan 31.

DOI:10.1155/2016/7867852
PMID:26942201
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4753052/
Abstract

AGEs are a heterogeneous group of molecules formed from the nonenzymatic reaction of reducing sugars with free amino groups of proteins, lipids, and/or nucleic acids. AGEs have been shown to play a role in various conditions including cardiovascular disease and diabetes. In this study, we hypothesized that AGEs play a role in the "multiple hit hypothesis" of nonalcoholic fatty liver disease (NAFLD) and contribute to the pathogenesis of hepatosteatosis. We measured the effects of various mouse chows containing high or low AGE in the presence of high or low fat content on mouse weight and epididymal fat pads. We also measured the effects of these chows on the inflammatory response by measuring cytokine levels and myeloperoxidase activity levels on liver supernatants. We observed significant differences in weight gain and epididymal fat pad weights in the high AGE-high fat (HAGE-HF) versus the other groups. Leptin, TNF-α, IL-6, and myeloperoxidase (MPO) levels were significantly higher in the HAGE-HF group. We conclude that a diet containing high AGEs in the presence of high fat induces weight gain and hepatosteatosis in CD-1 mice. This may represent a model to study the role of AGEs in the pathogenesis of hepatosteatosis and steatohepatitis.

摘要

晚期糖基化终末产物(AGEs)是一类由还原糖与蛋白质、脂质和/或核酸的游离氨基发生非酶促反应形成的异质性分子。已证明AGEs在包括心血管疾病和糖尿病在内的多种病症中发挥作用。在本研究中,我们假设AGEs在非酒精性脂肪性肝病(NAFLD)的“多重打击假说”中起作用,并促成肝脂肪变性的发病机制。我们测量了在高脂肪或低脂肪含量情况下,含有高AGE或低AGE的各种小鼠饲料对小鼠体重和附睾脂肪垫的影响。我们还通过测量肝脏上清液中的细胞因子水平和髓过氧化物酶活性水平,来测定这些饲料对炎症反应的影响。我们观察到,高AGE-高脂肪(HAGE-HF)组与其他组相比,体重增加和附睾脂肪垫重量存在显著差异。HAGE-HF组的瘦素、肿瘤坏死因子-α、白细胞介素-6和髓过氧化物酶(MPO)水平显著更高。我们得出结论,在高脂肪情况下,含有高AGEs的饮食会导致CD-1小鼠体重增加和肝脂肪变性。这可能代表了一种研究AGEs在肝脂肪变性和脂肪性肝炎发病机制中作用的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/3dd26a66ffda/BMRI2016-7867852.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/d77f4fd2e9a0/BMRI2016-7867852.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/98b00928dc73/BMRI2016-7867852.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/699200000621/BMRI2016-7867852.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/450f8146ed62/BMRI2016-7867852.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/6dea77a6e145/BMRI2016-7867852.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/3dd26a66ffda/BMRI2016-7867852.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/d77f4fd2e9a0/BMRI2016-7867852.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/98b00928dc73/BMRI2016-7867852.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/699200000621/BMRI2016-7867852.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/450f8146ed62/BMRI2016-7867852.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/6dea77a6e145/BMRI2016-7867852.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a89/4753052/3dd26a66ffda/BMRI2016-7867852.006.jpg

相似文献

1
Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice.晚期糖基化终末产物诱导CD-1野生型小鼠肥胖和肝脂肪变性。
Biomed Res Int. 2016;2016:7867852. doi: 10.1155/2016/7867852. Epub 2016 Jan 31.
2
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
3
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.半乳糖凝集素-3缺失增强肝脏脂肪变性,但减轻非酒精性脂肪性肝炎致肥胖小鼠模型中的炎症和白细胞介素-33依赖性纤维化。
Mol Med. 2015 May 22;21(1):453-65. doi: 10.2119/molmed.2014.00178.
4
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.膳食晚期糖基化终产物会加重非酒精性脂肪性肝病。
World J Gastroenterol. 2016 Sep 21;22(35):8026-40. doi: 10.3748/wjg.v22.i35.8026.
5
A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.高脂肪饮食和多次四氯化碳处理可诱导小鼠肝损伤和与非酒精性脂肪性肝炎相关的病理特征。
Clin Exp Pharmacol Physiol. 2013 Jul;40(7):422-30. doi: 10.1111/1440-1681.12102.
6
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.高脂饮食诱导肥胖和非酒精性脂肪性肝病小鼠肝脏和脂肪组织中调节脂肪生成的转录因子和基因表达改变。
Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.
7
Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD.脂肪组织特异性胰岛素受体敲除导致的脂肪营养不良会引发进行性非酒精性脂肪性肝病。
Diabetes. 2016 Aug;65(8):2187-200. doi: 10.2337/db16-0213. Epub 2016 May 10.
8
Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts.晚期糖基化终产物介导的炎症、肥胖和脂肪性肝病。
Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5172-5178. doi: 10.26355/eurrev_201711_13835.
9
Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.饮食调整可减轻肥胖相关性脂肪性肝病中的肝炎症和肝纤维化。
Obesity (Silver Spring). 2013 Jun;21(6):1189-99. doi: 10.1002/oby.20123. Epub 2013 May 10.
10
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.白藜芦醇通过减少脂肪生成和炎症来减轻高脂喂养小鼠的肝脂肪变性。
Nutrition. 2014 Jul-Aug;30(7-8):915-9. doi: 10.1016/j.nut.2013.11.016. Epub 2013 Dec 4.

引用本文的文献

1
Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors.基于晚期糖基化终末产物及其受体构建和评估代谢功能障碍相关脂肪性肝病的诊断模型
Front Med (Lausanne). 2025 Mar 28;12:1539708. doi: 10.3389/fmed.2025.1539708. eCollection 2025.
2
The relationship between advanced glycation end products, metabolic metrics, HbA and diabetic nephropathy.晚期糖基化终末产物、代谢指标、糖化血红蛋白与糖尿病肾病之间的关系。
Front Endocrinol (Lausanne). 2025 Mar 7;16:1468737. doi: 10.3389/fendo.2025.1468737. eCollection 2025.
3

本文引用的文献

1
Metaflammatory responses during obesity: Pathomechanism and treatment.肥胖期间的炎症反应:发病机制与治疗
Obes Res Clin Pract. 2016 Mar-Apr;10(2):103-13. doi: 10.1016/j.orcp.2015.10.012. Epub 2015 Nov 21.
2
Advanced glycation End-products (AGEs): an emerging concern for processed food industries.晚期糖基化终末产物(AGEs):加工食品行业日益关注的问题。
J Food Sci Technol. 2015 Dec;52(12):7561-76. doi: 10.1007/s13197-015-1851-y. Epub 2015 Aug 1.
3
The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease.
Liquid Chromatography with Tandem Mass Spectrometry Analysis of Carboxymethyl Lysine in Indonesian Foods.
液相色谱-串联质谱法分析印度尼西亚食品中的羧甲基赖氨酸。
Molecules. 2024 Mar 15;29(6):1304. doi: 10.3390/molecules29061304.
4
Increased dietary intake of ultraprocessed foods and mitochondrial metabolism alterations in pediatric obesity.超加工食品增加饮食摄入与儿童肥胖中线粒体代谢改变。
Sci Rep. 2023 Aug 3;13(1):12609. doi: 10.1038/s41598-023-39566-9.
5
Exercise Restores Hypothalamic Health in Obesity by Reshaping the Inflammatory Network.运动通过重塑炎症网络恢复肥胖状态下的下丘脑健康。
Antioxidants (Basel). 2023 Jan 28;12(2):297. doi: 10.3390/antiox12020297.
6
Association between diabetes and cancer. Current mechanistic insights into the association and future challenges.糖尿病与癌症的关联。对关联的当前机制见解及未来挑战。
Mol Cell Biochem. 2023 Aug;478(8):1743-1758. doi: 10.1007/s11010-022-04630-x. Epub 2022 Dec 24.
7
Artemisia alleviates AGE-induced liver complications via MAPK and RAGE signaling pathways modulation: a combinatorial study.黄花蒿通过调节 MAPK 和 RAGE 信号通路缓解 AGE 诱导的肝脏并发症:一项联合研究。
Mol Cell Biochem. 2022 Oct;477(10):2345-2357. doi: 10.1007/s11010-022-04437-w. Epub 2022 May 11.
8
Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress.辛伐他汀改善非酒精性脂肪性肝病的微循环功能并下调氧化和 ALE-RAGE 应激。
Nutrients. 2022 Feb 8;14(3):716. doi: 10.3390/nu14030716.
9
Physiological and metabolomic consequences of reduced expression of the Drosophila brummer triglyceride Lipase.果蝇 Brummer 甘油三酯脂肪酶表达降低的生理和代谢组学后果。
PLoS One. 2021 Sep 21;16(9):e0255198. doi: 10.1371/journal.pone.0255198. eCollection 2021.
10
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.晚期糖基化终产物:巴西 ELSA 研究中用于非酒精性脂肪性肝病风险分层的潜在生物标志物。
World J Gastroenterol. 2021 Aug 7;27(29):4913-4928. doi: 10.3748/wjg.v27.i29.4913.
晚期糖基化终末产物(AGEs)引发阿尔茨海默病的可能机制。
PLoS One. 2015 Nov 20;10(11):e0143345. doi: 10.1371/journal.pone.0143345. eCollection 2015.
4
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.脂多糖诱导的肿瘤坏死因子-α因子介导非酒精性脂肪性肝病中的促炎和促纤维化模式。
Oncotarget. 2015 Dec 8;6(39):41434-52. doi: 10.18632/oncotarget.5163.
5
New insights in leptin resistance mechanisms in mice.小鼠瘦素抵抗机制的新见解。
Front Neuroendocrinol. 2015 Oct;39:59-65. doi: 10.1016/j.yfrne.2015.09.004. Epub 2015 Sep 25.
6
Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.膳食晚期糖基化终产物(AGE)对循环中AGE的贡献:膳食脂肪的作用。
Br J Nutr. 2015 Dec 14;114(11):1797-806. doi: 10.1017/S0007114515003487. Epub 2015 Sep 22.
7
Hypothalamic Leptin and Ghrelin Signaling as Targets for Improvement in Metabolic Control.下丘脑瘦素和胃饥饿素信号传导作为改善代谢控制的靶点
Curr Pharm Des. 2015;21(25):3596-605. doi: 10.2174/1381612821666150710145428.
8
Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.血清中有毒晚期糖基化终产物(TAGE)水平可能是NASH发生发展过程中有前景的新型生物标志物。
Med Hypotheses. 2015 May;84(5):490-3. doi: 10.1016/j.mehy.2015.02.002. Epub 2015 Feb 10.
9
Dietary glycotoxins exacerbate progression of experimental fatty liver disease.饮食糖基化终产物加剧实验性脂肪肝疾病的进展。
J Hepatol. 2014 Apr;60(4):832-8. doi: 10.1016/j.jhep.2013.11.033. Epub 2013 Dec 6.
10
Advanced glycation end products and diabetic retinopathy.糖基化终产物与糖尿病视网膜病变。
Curr Med Chem. 2013;20(26):3234-40. doi: 10.2174/09298673113209990025.